| Login |
The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab
Rhodes, A. , Borthwick, D. , Sykes, R. , Al-Sam, S. and Paradiso, A. (2004) The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab. American Journal of Clinical Pathology, 122. pp. 51-60. ISSN 0002-9173 Full text not available from this repository Publisher's URL: http://dx.doi.org/10.1309/E9B5-5JYH-D84L-8Y17
Repository Staff Only: item control page |










